CIGNA debuts online Rx pricing guide for patients
BLOOMFIELD, Conn. Big insurance and pharmacy benefits management company CIGNA HealthCare has launched an updated version of its online Prescription Drug Price Quote tool for its health and PBM plan members as a price-comparison guide.
The web-based guide is available on the My Plans—Pharmacy page at www.mycigna.com. It offers Cigna Pharmacy members real-time, plan-specific cost comparisons for generic, brand name and available therapeutic alternative medications at 57,000 U.S. pharmacies, according to the health plan giant.
“Rather than relying on national average or regional discount information on retail pharmacy prices, the tool displays side-by-side comparisons of exactly what members would pay for brand named medications, available generics and low cost therapeutic options…based on their benefit plan, as well as the total cost of each medication,” Cigna noted in a statement.
CVS to offer flu vaccinations in more than 4,000 stores
WOONSOCKET, R.I. CVS/pharmacy plans to help Americans stay healthy by offering flu vaccinations in over 4,000 of its stores, the company said Wednesday.
The flu vaccinations, which will be offered to customers by Oct. 1, will vary in cost based on location. Vaccines for Medicare Part B beneficiaries who present their Medicare Card will be available at no charge, provided they have not assigned their Medicare benefits to a private Health Maintenance Organization. The offer to receive the flu shots will run through November.
“The annual flu shot clinics at CVS/pharmacy are part of our commitment to help communities stay healthy,” said Papatya Tankut, R.Ph., Vice President of Pharmacy Professional Services at CVS/pharmacy. “By offering convenient locations for flu vaccinations, we’re providing additional opportunities for people across the country to get vaccinated before the peak flu season begins.”
Last year, nearly 400,000 people received flu shots at CVS/pharmacy.
It is strongly recommended people ages 50 and older, and/or have chronic illnesses like diabetes and asthma, receive a yearly flu vaccination, according to the Centers for Disease Control.
Adams, Lipocine to develop new cough medicines
CHESTER, N.J. Lipocine and Adams Respiratory Therapeutics have entered in an agreement to develop new prescription adult cough products.
Under the terms of the agreement, Adams receives exclusive rights from Lipocine to develop and market multiple prescription adult cough products. Adams will be responsible for performing clinical development, regulatory submission, manufacture, and commercial operations. Lipocine will be responsible for completing the product development work.
Lipocine will have the opportunity to receive reimbursements and payments in exchange for completing development milestones. “Given the large and growing size of the respiratory market, and how patients can benefit from enhanced dosage forms and regimens, we are very pleased to partner with Adams, a company highly respected for its commercialization accomplishments,” said Dr. Mahesh Patel, president and chief executive officer of Lipocine.